Scynexis Inc SEC filings SCYX
Scynexis Inc has 744 filings in SEC EDGAR's recent list, going back to Jul 10, 2002. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Sep 28, 2026 (material agreement, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | May 8, 2026 | — |
| CORRESP | Letter to the SEC | May 6, 2026 | — |
| UPLOAD | Letter from the SEC | May 6, 2026 | — |
| EFFECT | Filing | Nov 27, 2023 | — |
| EFFECT | Filing | Nov 27, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 21, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 21, 2023 | — |
| CORRESP | Letter to the SEC | Nov 21, 2023 | — |
| CORRESP | Letter to the SEC | Nov 21, 2023 | — |
| EFFECT | Filing | Sep 15, 2021 | — |
| CORRESP | Letter to the SEC | Sep 13, 2021 | — |
| UPLOAD | Letter from the SEC | Sep 10, 2021 | — |
| EFFECT | Filing | Jan 8, 2021 | — |
| UPLOAD | Letter from the SEC | Jan 6, 2021 | — |
| CORRESP | Letter to the SEC | Jan 6, 2021 | — |
| EFFECT | Filing | Oct 1, 2020 | — |
| CORRESP | Letter to the SEC | Sep 28, 2020 | — |
| UPLOAD | Letter from the SEC | Sep 16, 2020 | — |
| EFFECT | Filing | May 11, 2020 | — |
| CORRESP | Letter to the SEC | May 7, 2020 | — |
| UPLOAD | Letter from the SEC | May 7, 2020 | — |
| EFFECT | Filing | Mar 29, 2019 | — |
| UPLOAD | Letter from the SEC | Mar 28, 2019 | — |
| CORRESP | Letter to the SEC | Mar 27, 2019 | — |
| CT ORDER | Filing | Mar 4, 2019 | — |
| EFFECT | Filing | Sep 14, 2018 | — |
| CORRESP | Letter to the SEC | Sep 11, 2018 | — |
| UPLOAD | Letter from the SEC | Sep 11, 2018 | — |
| CT ORDER | Filing | May 22, 2018 | — |
| CT ORDER | Filing | Mar 28, 2017 | — |
| CT ORDER | Filing | Jan 13, 2017 | — |
| CT ORDER | Filing | Jan 13, 2017 | — |
| CT ORDER | Filing | Jan 13, 2017 | — |
| CT ORDER | Filing | Dec 22, 2015 | — |
| EFFECT | Filing | Nov 16, 2015 | — |
| CORRESP | Letter to the SEC | Nov 12, 2015 | — |
| UPLOAD | Letter from the SEC | Nov 5, 2015 | — |
| NT 10-Q | Notification of late filing | Aug 14, 2015 | Jun 30, 2015 |
| EFFECT | Filing | Apr 22, 2015 | — |
| CT ORDER | Filing | Apr 16, 2015 | — |
| CT ORDER | Filing | Jan 29, 2015 | — |
| CT ORDER | Filing | May 5, 2014 | — |
| EFFECT | Filing | May 2, 2014 | — |
| CORRESP | Letter to the SEC | May 1, 2014 | — |
| UPLOAD | Letter from the SEC | Apr 30, 2014 | — |
| CORRESP | Letter to the SEC | Apr 30, 2014 | — |
| CORRESP | Letter to the SEC | Apr 30, 2014 | — |
| CORRESP | Letter to the SEC | Apr 25, 2014 | — |
| CORRESP | Letter to the SEC | Apr 25, 2014 | — |
| CORRESP | Letter to the SEC | Mar 31, 2014 | — |
| CORRESP | Letter to the SEC | Mar 31, 2014 | — |
| CERTNAS | Auto-generated paper document | Mar 31, 2014 | — |
| 8-A12B | Form 8-a 12(b) | Mar 19, 2014 | — |
| UPLOAD | Letter from the SEC | Mar 11, 2014 | — |
| UPLOAD | Letter from the SEC | Feb 19, 2014 | — |
| DRS/A | Filing | Jan 29, 2014 | — |
| UPLOAD | Letter from the SEC | Jan 21, 2014 | — |
| DRS | Filing | Dec 20, 2013 | — |
| D/A | Filing | May 18, 2012 | — |
| D/A | Filing | Feb 3, 2012 | — |
| D | Filing | Dec 16, 2011 | — |
| REGDEX | Auto-generated paper document | Mar 12, 2008 | — |
| REGDEX | Auto-generated paper document | Mar 2, 2006 | — |
| REGDEX | Auto-generated paper document | Jul 10, 2002 | — |
Showing 64 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SCYX (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Jersey City, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1178253
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.